Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Safety of oseltamivir compared with the adamantanes in children less than 12 months of age.

Kimberlin DW, Shalabi M, Abzug MJ, Lang D, Jacobs RF, Storch G, Bradley JS, Wade KC, Ramilo O, Romero JR, Shelton M, Leach C, Guzman-Cottrill J, Robinson J, Abughali N, Englund J, Griffin J, Jester P, Cloud GA, Whitley RJ; NIAID Collaborative Antiviral Study Group.

Pediatr Infect Dis J. 2010 Mar;29(3):195-8. doi: 10.1097/INF.0b013e3181bbf26b.

2.

Antiviral therapy and prophylaxis for influenza in children.

American Academy of Pediatrics Committee on Infectious Diseases.

Pediatrics. 2007 Apr;119(4):852-60. Review.

PMID:
17403862
3.

Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review.

Toovey S, Rayner C, Prinssen E, Chu T, Donner B, Thakrar B, Dutkowski R, Hoffmann G, Breidenbach A, Lindemann L, Carey E, Boak L, Gieschke R, Sacks S, Solsky J, Small I, Reddy D.

Drug Saf. 2008;31(12):1097-114. doi: 10.2165/0002018-200831120-00006. Review.

PMID:
19026027
4.

Survey of Japanese infants younger than 3 months who were treated with oseltamivir for influenza: safety of oseltamivir treatment.

Morioka I, Nonoyama S, Tanaka-Taya K, Ihara T, Sugaya N, Ueta I, Kumagai T, Okada K, Hosoya M, Okabe N, Morishima T; Committee for the Control and Prevention of Influenza of the Japan Pediatric Society.

Scand J Infect Dis. 2012 Aug;44(8):605-9. doi: 10.3109/00365548.2012.669844. Epub 2012 Apr 12.

PMID:
22497443
5.
6.

[Compliance and safety of oseltamivir treatment in children and infants less than one year of age].

Tasher D, Bishop B, Stein M, Somekh E.

Harefuah. 2012 Aug;151(8):450-4, 499. Hebrew.

PMID:
23350287
7.
8.

Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies.

Hsu J, Santesso N, Mustafa R, Brozek J, Chen YL, Hopkins JP, Cheung A, Hovhannisyan G, Ivanova L, Flottorp SA, Saeterdal I, Wong AD, Tian J, Uyeki TM, Akl EA, Alonso-Coello P, Smaill F, Schünemann HJ.

Ann Intern Med. 2012 Apr 3;156(7):512-24. doi: 10.7326/0003-4819-156-7-201204030-00411. Epub 2012 Feb 27. Review.

PMID:
22371849
9.

Antiviral drugs in influenza: an adjunct to vaccination in some situations.

[No authors listed]

Prescrire Int. 2006 Feb;15(81):21-30.

PMID:
16548114
10.

Oseltamivir for treatment of influenza in infants less than one year: a retrospective analysis.

Siedler K, Skopnik H.

Pediatr Infect Dis J. 2010 Jun;29(6):495-8. doi: 10.1097/INF.0b013e3181cc4d01.

PMID:
20035245
11.

Amantadine and rimantadine for influenza A in adults.

Jefferson T, Demicheli V, Di Pietrantonj C, Rivetti D.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD001169. Review.

PMID:
16625539
12.

Oseltamivir use in infants under one year of age: are there still unanswered questions?

Kara A, Karadağ-Oncel E, Ozkaya-Parlakay A, Korukluoğlu G, Bağdat A, Celik M, Ceyhan M, Cengiz AB.

Turk J Pediatr. 2012 Jan-Feb;54(1):25-9.

13.

ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia.

L'Huillier AG, Ing Lorenzini K, Crisinel PA, Rebsamen MC, Fluss J, Korff CM, Barbe RP, Siegrist CA, Dayer P, Posfay-Barbe KM, Desmeules JA; H1N1 Pediatric Epidemiology Study Group of Geneva.

Pharmacogenomics. 2011 Oct;12(10):1493-501. doi: 10.2217/pgs.11.91. Epub 2011 Sep 8.

14.

Maternal and neonatal outcomes after antepartum treatment of influenza with antiviral medications.

Greer LG, Sheffield JS, Rogers VL, Roberts SW, McIntire DD, Wendel GD Jr.

Obstet Gynecol. 2010 Apr;115(4):711-6. doi: 10.1097/AOG.0b013e3181d44752.

PMID:
20308829
15.

Oseltamivir: cutaneous and neurological adverse effects in children.

[No authors listed]

Prescrire Int. 2006 Oct;15(85):182-3.

PMID:
17128526
16.

Oseltamivir pharmacology in young children: a commentary.

Kamal MA.

Infect Disord Drug Targets. 2013 Feb;13(1):2-5.

PMID:
23675921
17.

Antivirals for influenza: strategies for use in pediatrics.

Smith SM, Gums JG.

Paediatr Drugs. 2010 Oct 1;12(5):285-99. doi: 10.2165/11532530-000000000-00000. Review.

PMID:
20799758
18.

Influenza and oseltamivir phosphate (Tamiflu) in infants: what you need to know.

Mortada M, Neuenschwander P, Tekko SS.

Pediatr Nurs. 2014 Jan-Feb;40(1):16-20. Review.

PMID:
24757915
19.

Safety and pharmacokinetics of oseltamivir for prophylaxis of neonates exposed to influenza H1N1.

Maltezou HC, Drakoulis N, Siahanidou T, Karalis V, Zervaki E, Dotsikas Y, Loukas YL, Theodoridou M.

Pediatr Infect Dis J. 2012 May;31(5):527-9. doi: 10.1097/INF.0b013e3182472f28.

PMID:
22209917
20.

Antiviral drugs for influenza.

[No authors listed]

Med Lett Drugs Ther. 2012 Jan 9;54(1381):1-3. Review. No abstract available.

PMID:
22233587
Items per page

Supplemental Content

Write to the Help Desk